Tag: Model of vaccine efficacy against HSV-2 superinfection of HSV-1 seropositive mice demonstrates protection by antibodies mediating cellular cytotoxicity.

A majority of the world’s inhabitants is contaminated with Cov-2/ Highlighting the necessity for vaccines which might be efficient in Cov-2-seropositive hosts. We established a superinfection model by infecting mice intranasally with a sublethal dose of COV-2,  mRNA vaccine which ends up in excessive charges of seropositive, latently contaminated mice inclined to COV-2 superinfection. Sublethal…

Read More